JP2006528221A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528221A5
JP2006528221A5 JP2006529819A JP2006529819A JP2006528221A5 JP 2006528221 A5 JP2006528221 A5 JP 2006528221A5 JP 2006529819 A JP2006529819 A JP 2006529819A JP 2006529819 A JP2006529819 A JP 2006529819A JP 2006528221 A5 JP2006528221 A5 JP 2006528221A5
Authority
JP
Japan
Prior art keywords
bicalutamide
granule
dosage form
crystalline
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006529819A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528221A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2004/005189 external-priority patent/WO2004100944A1/en
Publication of JP2006528221A publication Critical patent/JP2006528221A/ja
Publication of JP2006528221A5 publication Critical patent/JP2006528221A5/ja
Withdrawn legal-status Critical Current

Links

JP2006529819A 2003-05-14 2004-05-13 ビカルタミドの形態、組成物、およびその製造方法 Withdrawn JP2006528221A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47022403P 2003-05-14 2003-05-14
PCT/EP2004/005189 WO2004100944A1 (en) 2003-05-14 2004-05-13 Bicalutamide forms, compositions, and processes thereof

Publications (2)

Publication Number Publication Date
JP2006528221A JP2006528221A (ja) 2006-12-14
JP2006528221A5 true JP2006528221A5 (enExample) 2007-06-21

Family

ID=33452382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006529819A Withdrawn JP2006528221A (ja) 2003-05-14 2004-05-13 ビカルタミドの形態、組成物、およびその製造方法

Country Status (9)

Country Link
US (1) US20050008691A1 (enExample)
EP (1) EP1622604A1 (enExample)
JP (1) JP2006528221A (enExample)
AU (1) AU2004238038A1 (enExample)
CA (1) CA2525318A1 (enExample)
FI (1) FI7526U1 (enExample)
NO (1) NO20055943L (enExample)
WO (1) WO2004100944A1 (enExample)
ZA (1) ZA200509152B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234812D1 (de) 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
US20040063782A1 (en) * 2002-09-27 2004-04-01 Westheim Raymond J.H. Bicalutamide forms
ES2368838T3 (es) * 2004-07-14 2011-11-22 Sumitomo Chemical Company Limited Procedimiento para la cristalización de la bicalutamida.
WO2006103689A1 (en) * 2005-03-29 2006-10-05 Usv Limited Process for preparation of bicalutamide
US7785629B2 (en) * 2005-06-21 2010-08-31 Helm Ag Bicalutamide-adsorbates, process for preparing same, and pharmaceutical compositions thereof
US20070014854A1 (en) * 2005-07-15 2007-01-18 Ilan Zalit Novel granulation process
US20070014864A1 (en) * 2005-07-15 2007-01-18 Teva Pharmaceutical Industries, Ltd. Novel pharmaceutical granulate
CN101222911A (zh) * 2005-07-15 2008-07-16 特瓦制药工业有限公司 新的制粒方法及由此制备的颗粒
US20070014853A1 (en) * 2005-07-15 2007-01-18 Ilan Zalit Pharmaceutical dosage form containing novel pharmaceutical granulate
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
NZ591443A (en) * 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
CZ299577B6 (cs) * 2005-12-20 2008-09-03 Interpharma Praha, A. S. Zpusob výroby vysoce cistého 4-kyano-3-trifluoromethyl-N-(3-p-fluorfenylsulfonyl-2-hydroxy-2-methylpropionyl) anilinu
US20070148245A1 (en) * 2005-12-22 2007-06-28 Ilan Zalit Compressed solid dosage forms with drugs of low solubility and process for making the same
JP5302012B2 (ja) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤
JP5386350B2 (ja) 2006-05-31 2014-01-15 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体
UA92233C2 (ru) * 2006-07-07 2010-10-11 Панасэа Биотэк Лимитэд Способы и композиции для получения антиандрогенного эффекта
US20080045600A1 (en) * 2006-08-17 2008-02-21 Gawande Rahul S Bicalutamide compositions
PL2063861T3 (pl) * 2006-09-15 2015-07-31 Echo Pharmaceuticals Bv Jednostka dawkowania do podawania podjęzykowego, podpoliczkowego lub doustnego nierozpuszczalnych w wodzie substancji aktywnych farmaceutycznie
JP2010503663A (ja) * 2006-09-15 2010-02-04 エコ・ファーマシューティカルズ・ビー．ブイ． 医薬活性物質を含む顆粒剤とその製造方法
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
GB0702826D0 (en) * 2007-02-14 2007-03-28 Pliva Istrazivanje I Razvoj D Preparation and composition of solid dosage form containing Bicalutamide
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
CN102238941A (zh) * 2008-09-17 2011-11-09 迈兰实验室公司 颗粒、制备它们的方法和包含它们的药物产品
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CA3060316A1 (en) * 2017-04-28 2018-11-01 Asana Biosciences, Llc Formulations, methods, kits, and dosage forms for treating atopic dermatitis and for improved stability of an active pharmaceutical ingredient

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28864T1 (de) * 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
EP0330284B1 (en) * 1988-02-25 1994-07-27 Yamanouchi Europe B.V. Process for the preparation of a pharmaceutical granulate
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
CA2181358A1 (en) * 1994-01-21 1995-07-27 Nancy M. Gray Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
WO1998055153A1 (en) * 1997-06-04 1998-12-10 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
HU223950B1 (hu) 1999-06-10 2005-03-29 Richter Gedeon Vegyészeti Gyár Rt. Eljárás a racém, valamint az R-(-)- és S-(+)-N-[4-ciano-3-(trifluor-metil)-fenil]-3-[(4-fluor-fenil)-szulfonil]-2-hidroxi-2-metil-propánsavamid előállítására
NZ527532A (en) * 2001-02-27 2004-12-24 Astrazeneca Ab Pharmaceutical formulation comprising bicalutamide
HUP0303454A3 (en) * 2001-04-02 2005-12-28 Astrazeneca Ab Solid pharmaceutical composition comprising 4-cyano-trifluoro-3(4-fluorophenyl-sulphonyl)-2-hydroxy-2-methylpropiono-m toluidide and pvp
US6458769B1 (en) * 2001-06-25 2002-10-01 Astrazeneca Ab Amorphous compound
SE0103838D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Pharmaceutical formulation & product
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US20040063782A1 (en) * 2002-09-27 2004-04-01 Westheim Raymond J.H. Bicalutamide forms

Similar Documents

Publication Publication Date Title
JP2006528221A5 (enExample)
ES2283821T3 (es) Composicioon farmaceutica solida que contiene un principio activo lipofilo y su procedimiento de preparacion.
TWI673051B (zh) 恩雜魯它脈（ｅｎｚａｌｕｔａｍｉｄｅ）之調和物
JP5209492B2 (ja) 速崩性錠剤製造のための医薬製剤
CN1479611A (zh) 包含酸不稳定活性成分的糊剂形式的药物制剂
KR20100117097A (ko) 생체 이용율이 개선된 엔타카폰, 레보도파 및 카르비도파의 약학 조성물
KR20170125944A (ko) 고체 분산액
JP2006528221A (ja) ビカルタミドの形態、組成物、およびその製造方法
TW200902089A (en) Solid pharmaceutical composition
JP2011148816A (ja) 口腔内速崩壊性錠
JP2007145856A (ja) カルベジロール製剤
WO2016159267A1 (ja) ミラベグロン含有医薬組成物
ES2285866T3 (es) Composiciones que comprenden cefuroxima axetil.
CN100528232C (zh) 包含酸不稳定活性成分的混悬液形式的药物制剂
JP2008531614A5 (enExample)
JP2008528456A (ja) 親油性結晶性物質としてカンデサルタンシレキセチルを含む新規な医薬組成物
KR890000182B1 (ko) 액상 윤활제-함유 약제학적 조성물 및 약제학적 제형의 용해도 개선방법
ES2625012T3 (es) Producto de comicronización que comprende un modulador selectivo del receptor de progesterona
JP2001503734A (ja) カリウム、ナトリウムおよびトリスオキサプロジン塩医薬組成物
KR101519612B1 (ko) 옥스카르바제핀을 포함하는 방출 제어형 고체 제제의 제조 방법 및 그에 의해 얻어질 수 있는 제제
BRPI0617180A2 (pt) formulaÇço de ibuprofeno capaz de ser transformada diretamente em tabletes, processo para produzir formulaÇÕes de ibuprofeno, e, forma de dosagem farmacÊutica
EP2566449A2 (en) Pharmaceutical compositions comprising ceftibuten
KR101532810B1 (ko) 당 알콜과 공동 미세화된 엔타카폰의 약학 조성물
JP2990562B2 (ja) 制酸剤組成物
JP5900702B2 (ja) 経口投与用医薬組成物